ESCRS - Supplement: New Medical Therapies and Modern MIGs Address Unmet Needs in Galucoma and Cataract Patient Care ;
Supplements

Supplement: New Medical Therapies and Modern MIGs Address Unmet Needs in Galucoma and Cataract Patient Care

Supplement: New Medical Therapies and Modern MIGs Address Unmet Needs in Galucoma and Cataract Patient Care

According to the 2020 ESCRS Clinical Trends Survey, an average of 21% of patients prescribed one or two topical glaucoma medications and 27% of those prescribed more than two topical glaucoma medications to control their condition are not compliant (Figure 1). It is a significant number of patients.

Tags: glaucoma
Latest Articles
Which Farsighted Fix?

Evolving technologies opening new doors to best treatments.

Read more...

A New High for Hyperopia

Hyperopia patients can expect a rise in the array of treatments.

Read more...

Research Committee is Engine Driving the Future of ESCRS

Commitment to evidence-based medicine anchors studies and other projects.

Read more...

ESCRS EPICAT Study Updates

Early results suggest subconjunctival 10 mg triamcinolone an effective strategy for dropless cataract surgery.

Read more...

Fit for Duty

One surgeon’s tale of rising above stress.

Read more...

Second Global Consensus on Keratoconus

Forthcoming position paper to provide an updated and expanded view on evaluation and management.

Read more...

Know Thy Enemy

Read more...

Education for All Is What Makes ESCRS Unique

Read more...

Surgeons Split on Post-Surgery Inflammation Control

Leading surgeons weigh whether or how to use a dropless regimen after cataract surgery.

Read more...

Thinking of Selling Your Practice?

Planning an exit strategy is best begun early in your career.

Read more...